Characteristics of subject groups
| Adult controls | Children disease controls/comparison groups* | Patients with PAP | |||||||
|---|---|---|---|---|---|---|---|---|---|
| A | B | C | D | E | Adults | Children | Neonates | ||
| *A, atopy; B, oncological haematology; C, general paediatric pneumonology; D, tracheostoma; E, cystic fibrosis. | |||||||||
| †Age is given in years, except for the neonates with PAP in which age is given in months. | |||||||||
| No of subjects (F/M) | 12 (6/6) | 38 (12/26) | 38 (15/23) | 43 (20/23) | 25 (9/16) | 41 (22/19) | 9 (4/5) | 15 (7/8) | 3 (0/3) |
| Age (years) | |||||||||
| Median† | 42 | 6.4 | 6.0 | 3.2 | 3.2 | 15.4 | 38.2 | 1.6 | 0.6† |
| 25th–75th percentile | 38–44 | 2.8–8.9 | 4.2–11.1 | 1.8–6.9 | 1.6–4.8 | 11.5–22.6 | 34.6–45 | 1–3 | 0.4–0.8 |
| Range | 32–55 | 0.4–22 | 0.9–20 | 0.4–13 | 0.6–19 | 3.5–35 | 22–59 | 0.5–24 | 0.16–1.0 |
| No of serum samples | 12 | 38 | 38 | 28 | 0 | 33 | 7 | 4 | 0 |
| No of BAL samples | 0 | 0 | 0 | 30 | 25 | 16 | 4 | 15 | 3 |
| Pairs of BAL and serum samples | 0 | 0 | 0 | 15 | 0 | 8 | 2 | 4 | 0 |